Franklin Street Advisors Inc. NC Invests $12.66 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Franklin Street Advisors Inc. NC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 24,255 shares of the medical equipment provider’s stock, valued at approximately $12,660,000.

Several other institutional investors have also recently bought and sold shares of ISRG. Wealth Enhancement Advisory Services LLC grew its stake in shares of Intuitive Surgical by 73.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock valued at $132,657,000 after purchasing an additional 114,149 shares during the last quarter. Baker Tilly Wealth Management LLC boosted its position in Intuitive Surgical by 7.8% in the 4th quarter. Baker Tilly Wealth Management LLC now owns 1,255 shares of the medical equipment provider’s stock valued at $655,000 after buying an additional 91 shares during the last quarter. Private Client Services LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $210,000. Fulton Bank N.A. increased its position in Intuitive Surgical by 23.1% in the fourth quarter. Fulton Bank N.A. now owns 3,778 shares of the medical equipment provider’s stock worth $1,972,000 after purchasing an additional 708 shares during the period. Finally, One Wealth Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth about $255,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 over the last three months. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Up 0.1 %

Shares of NASDAQ:ISRG traded up $0.45 during midday trading on Friday, hitting $544.47. The stock had a trading volume of 762,625 shares, compared to its average volume of 1,176,261. The company has a market cap of $193.93 billion, a P/E ratio of 87.54, a PEG ratio of 5.31 and a beta of 1.39. The business’s 50-day simple moving average is $535.11 and its 200-day simple moving average is $493.61. Intuitive Surgical, Inc. has a 12 month low of $355.17 and a 12 month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on ISRG shares. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Truist Financial boosted their target price on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Finally, Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.